IPP Bureau
Illumina launches new assay for tumor profiling
By IPP Bureau - August 03, 2025
he new version features a streamlined sample-to-analysis workflow, built-in HRD detection, faster turnaround, and lower tissue requirements
Cellipont and CellVax expand partnership to advance manufacturing of immunotherapy for GI cancers
By IPP Bureau - August 03, 2025
The expanded partnership includes cGMP manufacturing, technology transfer for both drug substance and product
Sandoz to acquire Just–Evotec Biologics facility for $300 million
By IPP Bureau - August 03, 2025
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
NIH develops AI agent to improve accuracy of gene set analysis
By IPP Bureau - August 03, 2025
The system, called GeneAgent, cross-checks its own initial predictions for accuracy against information from established, expert-curated databases
FDA restrict 7-OH opioid products to protect consumers
By IPP Bureau - August 03, 2025
7-OH is a concentrated byproduct of the kratom plant and has shown potential for abuse by binding to opioid receptors
Johnson & Johnson submits additional data to FDA on psoriatic arthritis
By IPP Bureau - August 03, 2025
The submission is supported by results from the Phase 3b APEX study
GlaxoSmithKline Pharmaceuticals reports Q1 FY26 PAT at Rs. 205 Cr
By IPP Bureau - August 03, 2025
The performance was below anticipated levels, primarily due to external factors such as seasonal disruption that affected overall results
JB Pharma Q1 FY26 PAT up at 14% to Rs. 202 Cr
By IPP Bureau - August 02, 2025
Sun Pharmaceutical Q1 FY26 consolidated PAT falls by 20% to Rs. 2,278 Cr
By IPP Bureau - August 02, 2025
India Formulation sales accounted for 34.2% of total consolidated sales for the quarter
Iberia Pharmaceuticals to open Rs. 70 crore manufacturing unit in India
By IPP Bureau - August 02, 2025
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
Lilly's Mounjaro shows heart health benefits in head-to-head trial with Trulicity
By IPP Bureau - August 02, 2025
The SURPASS-CVOT study met its primary objective by demonstrating that Mounjaro (tirzepatide) was non-inferior to Trulicity
USPTO issues final rejection of Rampart IC's radiation shield patent claims
By IPP Bureau - August 02, 2025
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
Agilent and TIFR Hyderabad join hands to boost metabolism and health research
By IPP Bureau - August 02, 2025
Fermenta receives CEP by EDQM for Vitadee 100 SD
By IPP Bureau - August 01, 2025
Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin D3
Zydus completes acquisition of 85.6% stake in Amplitude Surgical
By IPP Bureau - August 01, 2025
